Close Menu

NEW YORK — The US Food and Drug Administration on Tuesday granted Emergency Use Authorization for Bio-Rad Laboratories' Platelia Total Ab immunoassay for SARS-CoV-2.

The assay is designed to detect all human antibodies against SARS-CoV-2 — including immunoglobulin M, immunoglobulin A, and immunoglobulin G — in serum and plasma in order to diagnose recent or prior infections. It may be used by any lab CLIA certified to perform high-complexity tests either manually or on automated immunoassay platforms.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.